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Inositol Pyrophosphates: Energetic, Omnipresent 
and Versatile Signalling Molecules
1 Introduction
Myo-inositol, a stereoisomer of cyclohexane-
hexol with one axial and five equatorial hydroxyl 
groups, is a component of biomolecules found 
in all forms of life.1 In eukaryotic cells, the phos-
phorylated derivates of myo-inositol include lipid 
phosphatidyl inositols and water-soluble inositol 
polyphosphates.1 Inositol hexakisphosphate (IP6), 
at a concentration range of 10–100 μM in yeast 
and animal cells and 500 μM in slime moulds, 
is the most abundant inositol polyphosphate in 
eukaryotes.2, 3 In the early 1990s, a distinct sub-
class of inositol polyphosphates containing ‘high 
energy’ pyrophosphate groups was identified in 
slime mould and mammalian cells.4–6 Since then 
several studies have characterized these inositol 
pyrophosphates (PP-IPs) and their functions (for 
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Abstract | Inositol pyrophosphates (PP-IPs) are a class of energy-rich 
signalling molecules found in all eukaryotic cells. These are deriva-
tives of inositol that contain one or more diphosphate (or pyrophos-
phate) groups in addition to monophosphates. The more abundant and 
best studied PP-IPs are diphosphoinositol pentakisphosphate (IP7) and 
bis-diphosphoinositol tetrakisphosphate (IP8). These molecules can 
influence protein function by two mechanisms: binding and pyrophos-
phorylation. The former involves the specific interaction of a particular 
inositol pyrophosphate with a binding site on a protein, while the latter is 
a unique attribute of inositol pyrophosphates, wherein the β-phosphate 
moiety is transferred from a PP-IP to a pre-phosphorylated serine resi-
due in a protein to generate pyrophosphoserine. Both these events can 
result in changes in the target protein’s activity, localisation or its interac-
tion with other partners. As a consequence of their ubiquitous presence 
in all eukaryotic organisms and all cell types examined till date, and their 
ability to modify protein function, PP-IPs have been found to participate 
in a wide range of metabolic, developmental, and signalling pathways. 
This review highlights many of the known functions of PP-IPs in the con-
text of their temporal and spatial distribution in eukaryotic cells.
Keywords: 5-Diphosphoinositol pentakisphosphate (IP7), Bis-diphosphoinositol tetrakisphosphate (IP8), 
Inositol hexakisphosphate (IP6), IP6 kinase (IP6K), Inositol phosphate
reviews see2, 7–23). The major PP-IPs, diphospho-
inositol pentakisphosphate, PP-IP5 (or IP7) and 
bis-diphosphoinositol tetrakisphosphate, [PP]2-
IP4 (or IP8), are derived by the addition of phos-
phate groups to pre-existing monophosphates 
on IP6 (Fig. 1). IP7 is the most abundant PP-IP, 
and its concentration ranges from 0.5 to 1.3 μM 
in yeast and mammalian cells.2 IP8 is present at 
much lower levels in most organisms, ranging 
from undetectable to approximately 50% of IP7 
levels in budding yeast24 and some mammalian 
cell lines.2, 25
The pathway of synthesis of inositol 
polyphosphates has been characterized in yeast, 
slime moulds, plants and animals. The simplest 
anabolic pathway, characterized in the yeast Sac-
charomyces cerevisiae (Fig. 1), involves the release 
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of I(1,4,5)P3 from PI(4,5)P2 by phospholipase C 
(PLC), subsequent phosphorylation of IP3 to IP4 
and IP5 by inositol polyphosphate multikinase 
(IPMK or Ipk2), and the conversion of IP5 to IP6 
by the IP5 2-kinase, Ipk1.
26 Inositol pyrophos-
phates are synthesized by two classes of enzymes, 
IP6 kinases and PP-IP5 kinases. IP6 kinases, iden-
tified by the Snyder group, convert IP6 to 5PP-IP5 
(also called 5-IP7).
27 S. cerevisiae have a single 
IP6 kinase, called Kcs1, whereas mammals have 
three isoforms, IP6K1, IP6K2 and IP6K3. PP-IP5 
kinases, identified independently by the York and 
Shears laboratories, convert 5PP-IP5 to 1,5[PP]2-
IP4 (IP8).
28, 29 These kinases can also synthesize an 
alternative form of IP7 (1PP-IP5, also called 1-IP7) 
from IP6.
30, 31 Yeast has a single PP-IP5 kinase 
(Vip1 in S. cerevisiae), and mammals have two 
isoforms, PPIP5K1 and PPIP5K2.29 1-IP7 is the 
minor IP7 isoform under normal conditions.
2, 32 
PP-IP4 and [PP]2-IP3 are derived from IP5 by 
the action of IP6 kinases and PP-IP5 kinases.
2, 33 
Diphosphoinositol polyphosphate phosphohy-
drolase, or DIPP (Ddp1 in S. cerevisiae) hydro-
lyzes the pyrophosphate moiety of inositol 
pyrophosphates, rapidly degrading IP8 to IP6
34 
(Fig. 1). Interestingly, the PPIP5Ks also possess a 
phosphatase domain which selectively cleaves the 
1-position β-phosphate of 1-IP7 and IP8, thus tar-
geting the products of the kinase domain.35, 36 A 
recent study identified another yeast phosphatase, 
Siw14, that specifically targets the 5-position 
β-phosphate of PP-IPs37 (Fig. 1).
As PP-IPs are found in all eukaryotic organ-
isms, they display many conserved and divergent 
Figure 1: The pathway of synthesis of inositol pyrophosphates. The simplest pathway in yeast starts with 
the formation of IP3 from PI(4,5)P2 by the action of phospholipase C (PLC). Subsequent phosphorylation 
by Ipk2 (IPMK in mammals) converts IP3 to IP4 and IP5. Ipk1 (IP5-2K in mammals) converts IP5 to IP6. 
Kcs1 (IP6Ks in mammals) phosphorylates IP6 to 5PP-IP5 (or 5-IP7). Vip1 (PPIP5Ks in mammals) acts on 
IP6 to form 1PP-IP5 (or 1-IP7) and on 5-IP7 to form 1,5[PP]2-IP4 (or IP8). Kcs1 can also convert 1-IP7 to 
IP8. 5PP-IP4 and 1,5[PP]2-IP3 are synthesised from IP5 by the action of Kcs1 and Vip1. IP6 kinases prefer 
IP6 over IP5 due to their higher affinity towards the former.
102 In yeast, the minor inositol pyrophosphates, 
5PP-IP4 and 1,5[PP]2-IP3 are detected only on deletion of Ipk1.
95 DIPP (diphosphoinositol polyphosphate 
phosphohydrolase), which has five isoforms in mammals and a single isoform, Ddp1, in yeast, hydrolyses 
diphosphate groups on IP7 and IP8 to form IP6, and on PP-IP4 and [PP]2-IP3 to form IP5.
2, 131 Siw14, an 
inositol pyrophosphate phosphatase in yeast, preferentially cleaves the C5 β-phosphate on PP-IPs.37 The 
yeast enzymes are depicted in purple, and mammalian enzymes are depicted in green and are brack-
eted. The undetermined inositol pyrophosphate structure is represented with an interrogation mark. Myo-
inositol contains five equatorial (parallel to the axis) and one axial (perpendicular to the axis) hydroxyl 
groups. Carbon atoms on the myo-inositol ring are numbered on the structures of PI(4,5)P2 and IP6.
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functions in yeast, plants and mammals. These 
small molecules participate in a wide array of 
cellular and organismal processes ranging from 
apoptosis and DNA repair to energy homeosta-
sis and blood clotting. Inositol pyrophosphates 
regulate protein function via two molecular 
mechanisms, (a) protein binding and (b) pro-
tein pyrophosphorylation (Fig. 2). The inositol 
pyrophosphates 1-IP7 and 5-IP7 show isomer-
specific binding to proteins to regulate their func-
tion.38–41 Conversely, any inositol pyrophosphate 
may act as a phosphate donor, transferring its 
β-phosphate to a pre-phosphorylated serine to 
form pyrophosphoserine, bringing about protein 
pyrophosphorylation42, 43 (Fig. 2). Pyrophos-
phorylation is an enzyme-independent reaction, 
requiring only the inositol pyrophosphate donor, 
the pre-phosphorylated protein acceptor, and 
divalent cations such as Mg2+. The acceptor ser-
ines are pre-phosphorylated by a protein kinase, 
usually CK1 or CK2, and occur in acidic serine 
sequence motifs, i.e. one or more Ser with neigh-
bouring Glu/Asp residues. IP7-mediated pyroph-
osphorylation of specific proteins can regulate 
glycolysis and rRNA synthesis in yeast,44, 45 and 
viral particle release and dynein motor driven ret-
rograde trafficking in mammalian cells.46, 47 Spe-
cific serine phosphatases such as PP1 and PP2C 
cannot remove the pyrophosphate group,42, 48 but 
alkaline phosphatase can depyrophosphorylate 
serine,48 suggesting that pyrophosphorylation is a 
reversible modification with many potential roles 
in cell signalling.
2  Temporal Regulation of Inositol 
Pyrophosphates
2.1  Detection and Measurement 
of PP‑IPs
The biochemical determination of PP-IP lev-
els presents several technical challenges, and till 
date there are no antibody-based or colourime-
try-based assays to detect these molecules. Most 
measurements have relied on monitoring radi-
olabelled [3H]inositol or [32P]phosphate after 
strong anion exchange HPLC-based resolution 
to separate individual inositol phosphates. The 
Mayr laboratory developed a post-HPLC column 
derivatization method that allows spectrophoto-
metric detection of unlabelled inositol polyphos-
phates,49 and was also able to resolve 1-IP7 and 
5-IP7.
30 A new method reported recently employs 
a monosaccharide binding resin (CarboPac™) to 
resolve 1-IP7 and 5-IP7 and has estimated that 
1-IP7 constitutes less than 2% of total IP7 in a 
human colon cancer cell line.32 All HPLC-based 
resolution methods however require deproteini-
zation of the sample using perchloric acid or 
Figure 2: Mechanism of regulation of protein function by PP-IPs. PP-IPs modulate protein function by two 
mechanisms: a direct binding to proteins in which the positively charged binding pockets formed by Lys/
Arg residues (shown in blue) electrostatically neutralise the high negative charge of the PP-IP molecule,125 
and b protein pyrophosphorylation, which involves the non-enzymatic transfer of the β-phosphate from a 




trichloroacetic acid, and employ acidic buffers to 
elute inositol phosphates from chromatography 
columns. These acidic conditions lead to hydroly-
sis of the β-phosphate moiety of PP-IPs, and their 
likely underestimation in cells and tissues.50 A 
simple method developed by the Saiardi labora-
tory employing high-percentage polyacrylamide 
gels to resolve IP6, IP7, and IP8 avoids the use of 
low pH buffers, thereby improving the efficiency 
and ease of PP-IP detection. The sensitivity of 
PP-IP detection was also improved by staining 
gels with the fluorescent dye 4′,6-diamidino-
2-phenylindole (DAPI),50 and by using titanium 
oxide (TiO2) beads to enrich for these phos-
phate containing molecules in cell and tissue 
extracts.25 These newer methods have suggested 
that earlier estimates of PP-IP levels may be off 
the mark.3 Nevertheless, while studies over the 
past twenty years employing HPLC methods may 
have underestimated the absolute levels of PP-IPs, 
the information on an increase or decrease in the 
concentration of these molecules, or changes in 
enzyme activity, is likely to be accurate. This sec-
tion therefore presents a summary of our current 
knowledge of the temporal changes in PP-IP lev-
els under different conditions.
While classical second messenger molecules 
like cAMP display acute changes in response to 
extracellular signals, most measurements sug-
gest that PP-IP levels change only marginally 
under certain conditions. The levels of PP-IPs are 
tightly regulated and these molecules display a 
high turnover rate, with studies showing that the 
IP7 pool can turn over ten times every 40 min,
51 
suggesting that pathways for the synthesis and 
utilisation of IP7 are constantly active in the cell. 
Several studies show that IP7 or IP8 levels vary in 
response to physiological stresses, during differ-
ent phases of the cell cycle, and over the course of 
development and ageing.
2.2  PP‑IPs Fluctuate in Response 
to Stress
IP7 and IP8 are involved in the cell’s response to 
different physiological stresses in mammals, yeast, 
and plants. In mammalian cells, hyper-osmotic 
stress can trigger an acute 25-fold increase in the 
level of IP8,
52 and thermal stress can increase IP8 
levels 3–4 fold.53 PPIP5K1, one of the mamma-
lian enzymes responsible for IP8 synthesis from 
5-IP7, is activated fourfold upon osmotic stress.
29 
Initial studies using protein kinase inhibitors sug-
gested that the ERK/MEK kinase pathway was 
responsible for these changes in IP8,
52, 53 but later 
data revealed that these kinase inhibitors actually 
acted via off-target effects on the cellular AMP/
ATP ratio54 (discussed later). Exposure of cells 
to apoptosis inducing drugs such as cisplatin or 
staurosporine has also been shown to elevate the 
levels of IP7 and to a lesser extent IP8
55 (discussed 
in detail later). Interestingly, exposure of neu-
trophils to nicotine or cigarette-smoke extract 
decreases IP7 levels, suggesting that IP7 plays 
a role in the pathogenesis of tobacco-induced 
chronic obstructive pulmonary disease.56
In budding yeast, the effect of phosphate 
starvation on inositol pyrophosphate levels has 
yielded conflicting results. One study observed 
an increase in cellular IP7 concentration during 
limiting extracellular phosphate levels,57 whereas 
others revealed a decrease in IP7 levels following 
phosphate starvation.58, 59 PP-IP levels in yeast 
decrease rapidly upon treatment with hydrogen 
peroxide, as a consequence of inhibition of Kcs1 
enzyme activity via oxidation of a cysteine resi-
due.24 Yeast lacking Kcs1 demonstrate reduced 
cell death upon exposure to H2O2
24 but are sen-
sitive to several other stresses, including osmotic 
and thermal stresses.60 Yeast carrying deletions 
for both kcs1 and vip1 genes have no PP-IPs and 
show no changes in transcription in response to 
osmotic, heat or oxidative stress, suggesting that 
PP-IPs are required for a cell to adapt in order to 
survive these stresses.61
Plant seeds are the most abundant source of 
IP6 (also known as phytic acid), which serves as a 
store for phosphorus, inositol, and cations 
required by the seedling during germination. 
Recently, two groups independently demon-
strated the presence of IP7 and IP8 in plant seeds 
and vegetative tissues.62, 63 These studies also 
identified two Vip1 orthologues in Arabidopsis 
that catalyse the formation of IP8 from IP7. 
Although no IP6K orthologue has been identified 
in plants, it was speculated that an unknown 
enzyme activity is responsible for plant IP7 syn-
thesis.63 It is also likely that the IP7 and IP8 iso-
mers found in plants are different from those 
occurring in yeast and mammals.63 The plant 
stress hormone abscisic acid was shown to cause a 
twofold increase in the levels of both IP7 and IP8, 
whereas treatment with the plant defence hor-
mone jasmonate led to a sustained twofold 
increase in IP8 but did not affect IP7 levels.
63 Fur-
ther probing the specific function of IP8 in jas-
monate signalling, this study suggested that IP8 
binds the F-box protein COI1 which is part of an 
E3 ligase complex responsible for proteasomal 
degradation of the transcriptional repressor pro-
tein JAZ. The combined binding of jasmonate 
and IP8 to the COI1-JAZ jasmonate coreceptor 
Jasmonate: A lipid based 
hormone that regulates 
plant growth and is required 
for plant defence responses 
against herbivores and envi-
ronmental stress
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complex facilitates JAZ degradation, thereby per-
mitting the expression of jasmonate responsive 
genes involved in plant defences against insect 
herbivores and fungal pathogens.
2.3  PP‑IP Changes During the Cell Cycle
PP-IP levels have also been shown to fluctuate 
during the cell cycle in both yeast and mammals. 
S. cerevisiae cells can be arrested in the G1 phase 
of the cell cycle by treatment with the α-factor 
mating pheromone.64 IP7 and IP8 levels increase 
by approximately twofold between 30 to 60 min 
after release from this arrest, in the time that cor-
responds to synchronised entry of the cells into 
the S phase.65 The levels of the PP-IPs decrease 
again during the G2/M phase. The activity of 
Kcs1 was shown to mirror these changes in IP7 
and IP8 levels, suggesting that signalling pathways 
operating during the cell cycle may post-trans-
lationally modify Kcs1 to regulate its activity.65 
Mammalian cells can be arrested in the G0 phase 
of the cell cycle by allowing them to grow to con-
fluence, and they can be arrested in early mitosis 
by treatment with nocodazole, which interferes 
with microtubule polymerization and prevents 
the formation of the mitotic spindle.66 When rat 
mammary tumour cells were synchronised by 
both these methods, IP7 was found to be twice 
as high in the G1 phase as compared with the 
other phases of the cell cycle where the basal 
levels of this PP-IP are approximately 0.6 μM.67 
The functional significance of these changes in 
PP-IP levels during the cell cycle is still unclear, 
but it is likely that one or more cell cycle modu-
lating factors may be regulated by IP7 binding or 
pyrophosphorylation.
2.4  PP‑IPs in Development and Ageing
Unlike most other eukaryotes, the slime moulds 
Dictyostelium discoideum and Polysphondylium 
pallidum display an abundance of PP-IPs, and are 
also the only documented organisms in which IP8 
is more abundant than IP7.
3, 68 Recent measure-
ments using TiO2 beads and polyacrylamide gel 
electrophoresis estimate that vegetative stage D. 
discoideum contain IP7 at 60 μM and IP8 at 
180 μM,3 and that IP8 levels go up approximately 
threefold during starvation induced develop-
ment, when these amoebae aggregate, form a 
multicellular “slug”, and eventually develop into a 
fruiting body. The chemoattractant cAMP 
released by D. discoideum during starvation has 
been shown to lead to a rapid and sustained 
three- to fourfold increase in IP7 and IP8 levels.
69 
IP7 competes with the lipid inositide PI(3,4,5)P3 
Chemotaxis: Phenomenon 
of movement of a cell or an 
organism in response to a 
chemical stimulus.
to bind the PH domain of the protein Crac, and 
interferes with Crac translocation to the plasma 
membrane. As Crac translocation is required for 
cAMP-dependent chemotaxis, it was postulated 
that IP7 is a negative regulator of chemotaxis, 
modulating the sensitivity of cells to cAMP 
stimulation.
IP7 levels have been shown to increase in mice 
as they age.39 While both IP6 and IP7 are higher in 
hepatocytes derived from 10-month-old as com-
pared with 2-month-old mice, the IP7/IP6 ratio 
increases more than twofold in older mice, and 
correlates with a decrease in insulin sensitivity. 
Like D. discoideum Crac, the PH domain of mam-
malian AKT can bind IP7, which competes with 
PI(3,4,5)P3 binding to inhibit membrane translo-
cation and activation of AKT in response to insu-
lin. Ip6k1−/− mice with reduced levels of IP7 and 
upregulated AKT signalling are thus more insulin 
sensitive as they age. Another study demonstrated 
increased IP7 production in ageing bone marrow 
derived mesenchymal stem cells as compared to 
young cells.70 Consequently, there is decreased 
AKT phosphorylation and activation in older 
cells, leading to increased sensitivity to hypoxic 
injury with age.
3  The Functions of PP‑IPs in Different 
Cellular Compartments
Technical limitations imposed by currently avail-
able methods for the detection of PP-IPs have 
translated into the lack of any convincing data on 
the subcellular compartmentalisation of PP-IPs. 
However, there are several studies on the tissue 
distribution and subcellular localisation of the 
IP6Ks and PPIP5Ks, which suggest that IP7 and 
IP8 are likely to be found in a variety of tissues 
and in all cell compartments. In S. cerevisiae, both 
PP-IP kinases, Kcs1 and Vip1 are located predom-
inantly in the cytoplasm (http://yeastgfp.yeast-
genome.org/), but several studies have revealed 
important functions for PP-IPs in various sub-
cellular compartments including the nucleus and 
vacuoles. In mice, Ip6k1 and Ip6k2 mRNA are 
expressed at varying levels in all tissues,27 whereas 
IP6K3 is highly expressed in the cerebellum.71, 72 
Ip6k1 mRNA shows highest expression in testes,27 
correlating with spermatogenesis failure observed 
in Ip6k1 knockout mice.73 Although protein 
overexpression studies show IP6K1 located in 
the cytoplasm and nucleus, IP6K2 mainly in the 
nucleus, and IP6K3 localised predominantly in 
the cytoplasm,71 such analyses are plagued with 
anomalies arising from high levels of unregulated 
protein expression, and often do not reflect the 
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behaviour of the endogenous protein. Ppip5k1 
mRNA is expressed in many human tissues, with 
greater abundance observed in skeletal muscle, 
heart and brain.74 Overexpressed PPIP5K1 and 
PPIP5K2 localise mainly to the cytoplasm,29, 74 
but PPIP5K2 has a nuclear localisation signal that 
is absent in PPIP5K1, enabling its translocation 
to the nucleus in a phosphorylation-dependent 
manner.75 Both the PPIP5K isoforms possess a 
lipid inositide binding domain distinct from their 
kinase domains, and agonist-stimulated produc-
tion of PI(3,4,5)P3 can lead to translocation of 
PPIP5K1 from the cytoplasm to the plasma mem-
brane.41, 76
As suggested by the ubiquitous expression 
and localisation of the kinases responsible for 
their synthesis, PP-IPs have been shown to par-
ticipate in a myriad functions in many different 
tissues and subcellular compartments. This sec-
tion describes several functions of these small 
molecules in different locations within a cell 
(Fig. 3).
3.1  Plasma Membrane
One of the most intriguing yet controversial 
functions of IP7 is its ability to compete with 
the lipid inositide PI(3,4,5)P3 for binding to PH 
domains in specific proteins, and thereby displac-
ing these proteins from the plasma membrane. 
The first demonstration that IP7 can compete 
with PI(3,4,5)P3 to bind a PH domain was in 
Dictyostelium69 (discussed earlier). This study 
also demonstrated that IP7 binds the PH domain 
of the mammalian kinase AKT with an affin-
ity comparable to I(1,3,4,5)P4, which mimics 
the PI(3,4,5)P3 head group. A subsequent study 
went on to show that the IP7-AKT interaction is 
physiologically relevant, as Ip6k1−/− mice show 
higher AKT activity, leading to increased insulin 
sensitivity and reduced weight gain in response 
to a high-fat diet.39 It has also been shown that 
enhanced PI(3,4,5)P3-dependent AKT activation 
in neutrophils derived from Ip6k1−/− mice leads 
to greater phagocytic and bactericidal ability in 
these cells.40 Although one report showed that 
Figure 3: Representation of cellular functions of inositol pyrophosphates in an eukaryotic cell. 1 IP7 physi-
ologically inhibits AKT signalling by competitively binding to the PH domain of AKT and thus preventing 
it from binding to PI(3,4,5)P3 (PIP3). IP7 and IP6K2 promote, 2 apoptosis and 3 formation of autophago-
somes. 4 PP-IPs regulate the cellular levels of ATP by their action on the glycolysis pathway and mito-
chondrial membrane potential. 5 IP7 is responsible for maintaining endoplasmic reticulum morphology 
in yeast cells. 6 IP7-mediated pyrophosphorylation regulates dynein binding to membranes and thereby 
influences Golgi morphology. 7 PP-IPs positively regulate the synthesis of polyphosphates in yeast vacu-
oles. 8 In pancreatic β cells, IP7 upregulates insulin secretion by increasing the readily releasable pool of 
insulin granules docked at the plasma membrane. 9 IP7 inhibits the synaptic exocytotic pathway in neu-
rons. In the nucleus, PP-IPs are responsible for 10 telomere length maintenance in yeast, 11 DNA repair 
via the homologous recombination (HR) and nucleotide excision repair (NER) pathways, and 12 epige-
netic modifications that influence chromatin remodelling to control global transcription. 13 In yeast, IP7 
influences ribosome biogenesis by regulating nucleolar rDNA transcription.
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IP7 is not able to displace PI(3,4,5)P3 from AKT 
in an in vitro binding assay,77 it was later demon-
strated that non-hydrolysable analogues of 5-IP7 
or 1-IP7 can inhibit AKT activation even in the 
presence of PI(3,4,5)P3.
78 A recent study revealed 
that chemically synthesized 5-IP7 released into 
mammalian cells is able to induce translocation 
of AKT from the plasma membrane to the cyto-
plasm.79 It has been shown that AKT and other 
PH domains bind 5-IP7 and IP6 with higher 
affinity as compared with 1-IP7 or IP8.
41 This 
study also suggested that PI(3,4,5)P3 dependent 
recruitment of PPIP5K1 to the plasma membrane 
would deplete subplasmalemmal 5-IP7 and IP6 by 
using them as substrates, thus providing positive 
feedback to PI(3,4,5)P3 binding by PH domains 
at the plasma membrane. Although the structural 
conundrum of how the AKT PH domain which 
specifically binds PI(3,4,5)P3 over PI(4,5)P2 can 
bind 5-IP7 better than IP6 remains unresolved, 
it is likely that binding of specific PP-IPs to dif-
ferent PH domains is a conserved mechanism by 
which these molecules regulate signalling at the 
plasma membrane.
3.2  Cytoplasm
Studies in yeast and mammalian cells have 
revealed many functions for PP-IPs in the cyto-
plasm, including key roles in energy metabolism, 
apoptosis and autophagy.
3.2.1 Energy Metabolism PP-IPs have been 
described as ‘energy sensors’ and ‘metabolic 
messengers’. This is because PP-IP levels can 
both reflect and regulate the cellular levels of 
ATP. The IP6Ks have a very low affinity for ATP, 
with a Km of approximately 1 mM, which lies 
within the range of cellular ATP concentrations. 
Consequently, fluctuations in ATP levels correlate 
with changes in the intracellular concentration 
of IP7. Lowering the cellular ATP concentration 
by treatment with sodium azide, oligomycin, 
or certain kinase inhibitors has been shown to 
significantly reduce the levels of PP-IPs.54, 80 
Interestingly, at a low ATP/ADP ratio, IP6Ks 
can switch to being ADP phosphotransferases, 
transferring the 1-phosphate from IP6 to ADP 
to generate I(2,3,4,5,6)P5,
81 depleting cytosolic 
IP6 and perhaps further lowering IP7 synthesis. 
It is possible that the dual enzymatic activity 
of IP6Ks allows them to function as cellular 
adenylate energy sensors, converting IP6 to IP7 
or IP5 under high or low energy conditions 
respectively, so that these products may 
transduce information on the cellular energy 
status to regulate different metabolic and 
signalling pathways.
PP-IPs in turn affect ATP levels by regulating 
glycolysis. S. cerevisiae lacking Kcs1 have a higher 
cellular ATP concentration than wild-type yeast.44 
It was shown that IP7 produced by Kcs1 pyroph-
osphorylates the major glycolytic transcription 
factor Gcr1, which is known to interact with 
Gcr2. In kcs1Δ cells, reduced pyrophosphoryla-
tion of Gcr1 increases its interaction with Gcr2, 
thereby increasing glycolytic flux.
In mammals, IP6K1 has been shown to influ-
ence fat accumulation by regulating adipocyte 
energy metabolism.82 The AMP-activated protein 
kinase (AMPK) signalling pathway augments the 
transformation of white adipose tissue to beige, 
enhancing energy expenditure in the form of heat, 
and correlating inversely with type II diabetes 
and fat-induced obesity. IP6 causes stimulatory 
phosphorylation of AMPK, thereby activating the 
pathway that leads to browning of white adipose 
tissue. Specific deletion of IP6K1 in mouse adipo-
cytes led to increased thermogenic energy expend-
iture in these cells, presumably due to increased 
availability of IP6. It was suggested that this phe-
nomenon, coupled with increased insulin sensitiv-
ity due to AKT activation (described earlier), leads 
to reduced weight gain when Ip6k1−/− mice are 
provided a high-fat diet.
3.2.2 Apoptosis 5-IP7 produced by IP6K2 has 
been shown to upregulate apoptotic signalling 
pathways in many mammalian cells and tissues. 
Overexpression of either of the three IP6K 
isoforms in various cancer cell lines under normal 
as well as stress conditions leads to increased cell 
death.55, 83, 84 However, siRNA mediated depletion 
of only IP6K2 and not IP6K1 or IP6K3 abrogated 
cell death, suggesting that IP6K2 is the only 
isoform that is physiologically capable of inducing 
apoptosis.55, 85 Work by the Lindner group 
revealed that overexpressed IP6K2 in untreated 
cancerous or non-cancerous cells is mainly 
cytoplasmic and upon apoptotic induction it 
translocates to the nucleus.84 IP6K2 has a nuclear 
localization signal, the removal of which keeps the 
protein in the cytoplasm, lowering its pro-
apoptotic effect. The Snyder group showed that 
overexpressed IP6K2 translocates to the 
mitochondria upon cytotoxic stress and 
co-localizes with the pro-apoptotic protein Bax.55 
Overexpression of catalytically inactive IP6K2 did 
not promote stress-induced apoptosis, indicating 
that the pro-apoptotic function of IP6K2 relies on 
IP7 synthesis. Indeed, the levels of IP7 were found 
Glycolytic flux: Rate at which 
molecules proceed through 
the glycolysis pathway.
Apoptosis: Regulated or 




to be higher in cells undergoing cytotoxic stress as 
compared with untreated cells. IP6K2 has been 
shown to promote apoptosis by acting on several 
signalling pathways. IP7 binding to the PH domain 
of AKT inhibits AKT-dependent prosurvival 
signalling,69 indirectly enhancing apoptosis.55, 86 
IP6K2 also influences apoptotic signalling via the 
transcription factor p53, which is known to 
activate both pro- and anti-apoptotic genes. 
Kinase activity independent direct binding of 
IP6K2 to p53 augments apoptosis by 
downregulating expression of p21, which is 
responsible for stressed cells choosing cell cycle 
arrest instead of apoptosis.87 IP6K2 also binds 
TTI1, a protein that forms part of the TTT 
co-chaperone complex that stabilises the protein 
kinases DNAPKcs and ATM.88 IP7 synthesized by 
IP6K2 binds the protein kinase CK2 and promotes 
its phosphorylation of the TTT complex, which in 
turn stabilises DNAPKcs and ATM, leading to 
increased phosphorylation of p53 and activation 
of cell death. In another study, IP6K2 binding to 
TRAF2 (TNF receptor associated factor) prevents 
TAK1 (transforming growth factor β-activated 
kinase) phosphorylation and subsequent NFκB 
activation, sensitizing cells to TNF-α induced 
apoptosis.89 The heat shock protein HSP90 has 
been shown to bind IP6K2 and inhibit its catalytic 
activity, thereby protecting cells from apoptosis 
and augmenting cell survival.90 The importance 
of IP6K2 in promoting apoptosis is also reflected 
in phenotypes observed in Ip6k2 knockout mice.91 
Chronic exposure to the UV mimetic carcinogen 
4-nitroquinoline 1-oxide (4NQO) led to a fourfold 
increased incidence of invasive squamous cell 
carcinoma of the oral cavity and oesophagus in 
Ip6k2−/− mice as compared with their wild-type 
littermates. This was attributed at least in part to 
resistance to cell death in tissues lacking IP6K2. 
Whole genome expression profiling of tissues 
from Ip6k2−/− as compared with Ip6k2+/+ mice 
showed upregulation of certain oncogenes and 
downregulation of tumour suppressor genes, 
suggesting that other pathways regulated by IP6K2 
also impinge upon survival versus death signals to 
influence carcinogenesis.
3.2.3 Autophagy IP6Ks in yeast and mammals 
have also been shown to participate in autophagy, 
a process by which cytoplasmic proteins and 
organelles are degraded. Autophagy is initiated 
with the formation of the phagophore, a double 
membrane that begins to engulf macromolecules 
and organelles in the cytoplasm.92 The phagophore 
membrane closes to form an autophagosome, 
which fuses with a lysosome, leading to degradation 
and recycling of the engulfed components. Budding 
yeast deficient in Kcs1 display undetectable 
levels of PP-IPs and exhibit a reduction in the 
number and size of autophagosomes formed 
upon nitrogen starvation.93 kcs1Δ yeast show 
mislocalisation of phagophore assembly sites to 
the plasma membrane, suggesting that Kcs1 is 
required for normal autophagosome formation. 
Overexpression of IP6Ks in mammalian cells led 
to an increase in the number of stress-induced 
autophagosomes as compared with control 
cells, and reduced expression of IP6Ks using 
RNA interference suppressed autophagosome 
formation.94 Expression of an inactive IP6K had 
no effect, revealing that autophagosome formation 
is IP7 dependent. The evolutionarily conserved 
protein kinase mTOR is a master regulator of cell 
growth and metabolism, and negatively regulates 
autophagy. In human cells, IP6K expression levels 
showed an inverse correlation with mTOR activity, 
suggesting that IP7 may promote autophagy via 
the mTOR signalling pathway.94
3.3  Membrane Bound Organelles
PP-IPs are not membrane permeant, and there is 
little evidence to suggest that PP-IP synthesising 
enzymes are localised within membrane-bound 
organelles in mammalian cells. However, changes 
in intracellular PP-IP levels have been shown to 
impact normal function in several membrane 
bound organelles, suggesting that these molecules 
may be synthesized within these organelles, may 
act on the cytoplasmic face of the membrane, 
or may be transported across membranes by yet 
unknown mechanisms.
3.3.1 Mitochondria Yeast devoid of Kcs1 and 
mouse embryonic fibroblasts (MEFs) lacking 
IP6K1 have dysfunctional mitochondria, which 
display a significantly lower oxygen consumption 
as compared with their wild-type counterparts.44 
Without IP6K1, mitochondria are unable to 
generate the membrane potential required for 
ATP production, and are also deficient in the 
respiratory chain protein cytochrome c oxidase. 
Despite these mitochondrial defects, kcs1Δ yeast 
show higher ATP levels because of increased 
glycolytic flux (discussed earlier). However, 
kcs1Δ yeast shows a decreased growth rate as 
compared with wild-type cells, which could be 
partly attributed to defects in the bio-synthesis 
of major macromolecules like fatty acids and 
nucleotides that depend on enzymes of the 
mitochondria.44
9Inositol Pyrophosphates: Energetic, Omnipresent and Versatile Signalling Molecules
1 3
3.3.2 Endoplasmic Reticulum The endoplasmic 
reticulum (ER) is generally nondescript and 
parallel to the plasma membrane in wild-type 
budding yeast, whereas in kcs1Δ cells, it appears 
hypertrophied and perpendicular to the plasma 
membrane.95 This suggests that PP-IPs have a 
role to play in ER function. However, there was 
no apparent defect in the secretion of newly 
synthesised proteins into the medium by kcs1Δ 
yeast, suggesting that ER functions remain largely 
unaffected in the absence of significant levels of 
PP-IPs. There are no studies examining whether 
PP-IPs influence ER structure or function in 
mammalian cells.
3.3.3 Golgi Our recent studies show that 
Ip6k1−/− MEFs display a fragmented Golgi 
morphology when compared with Ip6k1+/+ 
MEFs.47 This phenotype was restored by the 
expression of catalytically active IP6K1 but not 
by the inactive protein, suggesting that PP-IPs 
are essential to maintain Golgi morphology. The 
pericentriolar position of the Golgi apparatus in 
mammalian cells is dependent on the cytoplasmic 
motor protein dynein, and the Golgi appears 
fragmented if dynein function is compromised.96 
Further analysis showed that PP-IPs regulate 
dynein binding to membranes, and thereby 
influence Golgi morphology (discussed later).
3.3.4 Lysosomes and Related Organelles The 
number and distribution of lysosomes marked by 
the protein LAMP2 (lysosome associated 
membrane protein 2) appears unaltered in 
Ip6k1−/− MEFs (Chanduri and Bhandari, 
unpublished). However, PP-IPs have an important 
function in yeast vacuoles, which are lysosome-
like organelles.97 Yeast vacuoles are the site of 
synthesis and storage of inorganic polyphosphates 
(polyP), which are linear chains of orthophosphate 
moieties linked via phosphoanhydride bonds.98 
PolyP are found in all life forms and are involved 
in diverse physiological functions like energy 
metabolism, transcription regulation, and blood 
clotting.98 An intriguing link was established 
between PP-IPs and polyP, when it was observed 
that kcs1Δ yeast also have substantially reduced 
levels of polyP.99 Our work showed that the link 
between PP-IPs and polyP levels is also conserved 
in mammals.100 Ip6k1−/− mice have reduced levels 
of polyP in platelet dense granules, which are 
lysosome-related organelles. Consequently, these 
mice display delayed clotting time and altered clot 
architecture, making them less susceptible to 
Thromboembolism: Ob-
struction of a blood vessel by 
a blood clot.
thromboembolism. Elegant structural and 
biochemical studies from the Mayer laboratory 
uncovered the molecular link between PP-IPs and 
polyP. The first study identified that the yeast 
vacuolar transport chaperone (VTC) complex 
generates polyP from ATP, with the subunit VTC4 
responsible for enzyme activity.101 A recent study 
determined that multiple subunits of the VTC 
complex, including VTC4, contain an SPX 
domain, which has a positively charged surface 
that can specifically bind inositol polyphosphates.59 
Binding of 5-IP7 to this domain enhances VTC-
dependent polyP synthesis in isolated vacuoles, 
suggesting that PP-IPs modulate polyP synthesis 
by allosteric regulation of the polyP polymerase. 
As the levels of 5-IP7 have been shown to decrease 
upon phosphate starvation in yeast,58, 59 it was 
speculated that PP-IPs may act as sensors of 
inorganic phosphate (Pi) levels in the cytoplasm 
and communicate Pi fluctuations to SPX domains, 
which then interact with various proteins to 
regulate Pi uptake, transport and storage.59
3.3.5 Vesicles Several studies have investigated 
the role of PP-IPs in vesicle trafficking processes. 
Budding yeast lacking Kcs1 show abnormally 
small and fragmented vacuoles,102 which reflect 
a defect in the endocytosis pathway.95 In these 
cells, the endosomes formed upon endocytosis 
fail to fuse with vacuoles and accumulate as 
large multilamellar endosomal intermediates. 
The exact mechanism by which PP-IPs regulate 
endocytosis remains unclear. PP-IPs synthesized 
by IP6K1 are essential to ensure normal insulin 
secretion in mammals. Ip6k1−/− mice have lower 
serum insulin levels as compared with their 
wild-type littermates,73 and in pancreatic β cells, 
5-IP7 synthesized by IP6K1 upregulates insulin 
secretion.103 5-IP7 increases the readily releasable 
pool of insulin containing granules which are 
docked at the plasma membrane, ready for the 
first phase of exocytosis upon glucose uptake 
by β cells.103 IP6K1 can also influence synaptic 
vesicle exocytosis. IP6K1 acts independent of 
its catalytic activity to bind GRAB, a guanine-
nucleotide exchange factor (GEF) for the small 
G-protein Rab3A, which is a negative regulator 
of synaptic vesicle exocytosis.104 IP6K1 binding 
to GRAB inhibits the activity of Rab3A to 
augment neurotransmitter release from synaptic 
vesicles. In contrast, a recent study showed 
that 5-IP7 synthesized by IP6K1 can inhibit 
the synaptic exocytotic pathway by interacting 




protein in the synaptic vesicle membrane and 
promotes vesicle fusion.105 5-IP7 (but not 1-IP7 
or IP6) binds and restrains synaptotagmin in 
a fusion-incompetent conformation to inhibit 
neurotransmitter release. These contrasting 
studies suggest that PP-IPs and their kinases can 
regulate exocytosis via multiple non-overlapping 
pathways in different cell types and tissues.
In addition to regulating vesicle fusion events, 
PP-IPs have also been shown to influence vesicle 
transport along microtubules. In the first dem-
onstration of how serine pyrophosphorylation 
can regulate cellular processes, the Saiardi labo-
ratory showed that pyrophosphorylation of the β 
subunit of the adaptor protein complex AP3 can 
regulate the release of HIV-1 virus like particles 
from mammalian cells.46 5-IP7-mediated pyroph-
osphorylation of AP3B1 was shown to inhibit 
its interaction with the microtubule plus end-
directed kinesin motor protein Kif3A, thereby 
lowering kinesin-dependent intracellular traf-
ficking of HIV1 virus like-particles. Recent work 
from our laboratory has shown that 5-IP7-medi-
ated protein pyrophosphorylation can also regu-
late dynein-motor driven microtubule minus-end 
directed vesicle trafficking.47 We found that 
pyrophosphorylation of Ser51 on the dynein-
intermediate chain (IC) is important for its inter-
action with the p150Glued subunit of the dynactin 
complex, and is required to recruit dynein to vesi-
cles. Ip6k1−/− MEFs have reduced interaction 
between dynein IC and p150Glued, and as a conse-
quence have defects in several dynein-dependent 
trafficking processes, including endosomal sort-
ing of transferrin and Golgi morphology.
3.4  Actin Cytoskeleton
The role of PP-IPs in actin cytoskeleton regula-
tion was first identified by studies in the fission 
yeast, Schizosaccharomyces pombe, which pos-
sesses a Vip1 orthologue named Asp1.28 Asp (arp, 
sop, profilin interactor) was originally identi-
fied as a high-copy suppressor of a mutation in 
Arp3, which is part of the actin-related protein 
complex Arp2/3, an essential component of the 
actin cytoskeleton in yeast.106 asp1Δ yeast exhibit 
temperature sensitive morphological defects 
and defects in polarised growth due to a disor-
ganised actin cytoskeleton. Later, when Vip1 and 
Asp1 were found to possess inositol pyrophos-
phate synthesis activity, it was observed that the 
kinase activity of Asp1 was essential to maintain 
the normal rod-shaped morphology of fission 
yeast.28
Cytoskeleton: A network of 
protein filaments and tubules 
in the cytoplasm of cells, 
which gives them shape.
Remodelling of the actin cytoskeleton is 
essential for cell migration and invasion associ-
ated with carcinogenesis. Recent studies have 
shed light on the role of IP7 in the promotion of 
tumour growth and metastasis using in vitro and 
in vivo approaches.107, 108 The Snyder group 
showed that gene deletion of Ip6k2 in HCT116 
human colorectal cancer cells and Ip6k2 knock-
down in breast and lung cancer cell lines led to a 
reduction in focal adhesion kinase (FAK) phos-
phorylation, correlating with reduced cell spread-
ing and cell–matrix adhesion.107 Epithelial to 
mesenchymal transition properties including cell 
migration and invasion were also significantly 
reduced in these cells. Subcutaneous xenograft of 
Ip6k2 knockout HCT116 cells in immune-com-
promised mice led to tumours that were smaller 
in size as compared with those formed by parent 
HCT116 cells. This study also worked out the 
molecular mechanism underlying the influence 
of IP6K2 on actin cytoskeleton remodelling. Liver 
Kinase B1 (LKB1), which suppresses FAK phos-
phorylation dependent migration, invasion and 
metastasis, is localised in the cytosol and is acti-
vated upon phosphorylation by PKC-zeta. IP6K2 
binds LKB1 and generates IP7 which through an 
unknown mechanism leads to reduced PKC-zeta 
dependent LKB1 phosphorylation, causing its 
nuclear sequestration and inactivation, thus 
increasing FAK activity to facilitate actin remod-
elling. Recent work from our laboratory showed 
that IP6K1 also promotes cell migration and 
invasion.108 Knockdown of IP6K1 expression in 
cancer cells leads to a reduction in cell migration, 
invasion and anchorage-independent growth. 
Ip6k1 knockout mice fed with the oral carcinogen 
4NQO showed reduced progression from epithe-
lial dysplasia to invasive carcinoma in the upper 
aerodigestive tract as compared with their wild-
type littermates, showing that IP6K1 is also 
required to promote cell invasion in vivo. This 
phenotype of resistance to aerodigestive tract car-
cinoma seen in Ip6k1 knockout mice is in direct 
contrast to the outcome of 4NQO treatment 
observed in Ip6k2 knockout mice (described ear-
lier), which showed a higher incidence of carci-
noma.91 These contrasting observations suggest 
that in aerodigestive tract epithelial cells, IP6K1 is 
responsible for promoting carcinogenesis, 
whereas the predominant function of IP6K2 is to 
prevent transformation by promoting apoptosis.
It was recently shown that the third IP6 kinase 
isoform, IP6K3, also influences the actin cytoskel-
eton. This study examined the effect of the loss of 
Ip6k3 in specialised neurons in the cerebellum 
Dysplasia: Enlargement of an 
organ or a tissue due to exces-
sive proliferation of cells of an 
abnormal type.
Metastasis: Spread of cancer 
cells from one part of the 
body to another part via the 
blood or lymphatic system.
Dendritic spines: Small 
protrusion from a neuron’s 
dendrite which receives signal 
from a single axon at the 
synapse.
Synapse: Junction between 
two nerve cells, which consists 
of a small gap across which 
impulses pass by diffusion of 
a neurotransmitter.
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Remodelling of the actin cytoskeleton is 
essential for cell migration and invasion associ-
ated with carcinogenesis. Recent studies have 
shed light on the role of IP7 in the promotion of 
tumour growth and metastasis using in vitro and 
in vivo approaches.107, 108 The Snyder group 
showed that gene deletion of Ip6k2 in HCT116 
human colorectal cancer cells and Ip6k2 knock-
down in breast and lung cancer cell lines led to a 
reduction in focal adhesion kinase (FAK) phos-
phorylation, correlating with reduced cell spread-
ing and cell–matrix adhesion.107 Epithelial to 
mesenchymal transition properties including cell 
migration and invasion were also significantly 
reduced in these cells. Subcutaneous xenograft of 
Ip6k2 knockout HCT116 cells in immune-com-
promised mice led to tumours that were smaller 
in size as compared with those formed by parent 
HCT116 cells. This study also worked out the 
molecular mechanism underlying the influence 
of IP6K2 on actin cytoskeleton remodelling. Liver 
Kinase B1 (LKB1), which suppresses FAK phos-
phorylation dependent migration, invasion and 
metastasis, is localised in the cytosol and is acti-
vated upon phosphorylation by PKC-zeta. IP6K2 
binds LKB1 and generates IP7 which through an 
unknown mechanism leads to reduced PKC-zeta 
dependent LKB1 phosphorylation, causing its 
nuclear sequestration and inactivation, thus 
increasing FAK activity to facilitate actin remod-
elling. Recent work from our laboratory showed 
that IP6K1 also promotes cell migration and 
invasion.108 Knockdown of IP6K1 expression in 
cancer cells leads to a reduction in cell migration, 
invasion and anchorage-independent growth. 
Ip6k1 knockout mice fed with the oral carcinogen 
4NQO showed reduced progression from epithe-
lial dysplasia to invasive carcinoma in the upper 
aerodigestive tract as compared with their wild-
type littermates, showing that IP6K1 is also 
required to promote cell invasion in vivo. This 
phenotype of resistance to aerodigestive tract car-
cinoma seen in Ip6k1 knockout mice is in direct 
contrast to the outcome of 4NQO treatment 
observed in Ip6k2 knockout mice (described ear-
lier), which showed a higher incidence of carci-
noma.91 These contrasting observations suggest 
that in aerodigestive tract epithelial cells, IP6K1 is 
responsible for promoting carcinogenesis, 
whereas the predominant function of IP6K2 is to 
prevent transformation by promoting apoptosis.
It was recently shown that the third IP6 kinase 
isoform, IP6K3, also influences the actin cytoskel-
eton. This study examined the effect of the loss of 
Ip6k3 in specialised neurons in the cerebellum 
Dysplasia: Enlargement of an 
organ or a tissue due to exces-
sive proliferation of cells of an 
abnormal type.
Metastasis: Spread of cancer 
cells from one part of the 
body to another part via the 
blood or lymphatic system.
Dendritic spines: Small 
protrusion from a neuron’s 
dendrite which receives signal 
from a single axon at the 
synapse.
Synapse: Junction between 
two nerve cells, which consists 
of a small gap across which 
impulses pass by diffusion of 
a neurotransmitter.
called Purkinje cells, which express high levels of 
IP6K3.72 Behavioural tests revealed that Ip6k3 
knockout mice manifest defects in motor learn-
ing and coordination. These mice showed abnor-
malities in synapse number and structure of 
Purkinje cells. The shape of Purkinje cell den-
dritic spines is regulated by the arrangement and 
attachment of cytoskeletal elements including 
actin and actin-regulating proteins such as spec-
trins and adducins.109, 110 Spectrin is a structural 
protein that forms a mesh on the cytoplasmic face 
of the plasma membrane and adducin binds 
spectrin to promote its association with filamen-
tous actin.111 IP6K3, but not IP6K1 or IP6K2, was 
shown to bind spectrin and adducin, and cells 
lacking IP6K3 showed reduced spectrin-adducin 
interaction.72 Catalytically active and inactive 
forms of IP6K3 can promote adducin binding to 
spectrin, providing another example of IP6 
kinases functioning as structural scaffolds inde-
pendent of their ability to synthesize PP-IPs.
3.5  Nucleus
The work of several laboratories has shed light 
on the importance of PP-IPs in the regulation of 
essential housekeeping functions in the nucleus, 
including the maintenance of genome integrity 
and regulation of transcription.
3.5.1 Genome Integrity PP-IPs have been 
shown to participate in many processes that are 
responsible for maintaining the integrity of the 
eukaryotic genome. Telomeres are protein–DNA 
structures present at the ends of linear eukaryotic 
chromosomes to protect them against degradation. 
The repetitive DNA sequences present in 
telomeres shorten with each cell division and 
telomere shortening correlates with ageing. Two 
independent studies showed that PP-IPs play a role 
in maintaining the length of telomeres in budding 
yeast. Using yeast mutants deleted for various 
inositol phosphate biosynthetic enzymes, it was 
shown that that the loss of PP-IPs led to telomere 
lengthening, whereas their overproduction led to 
shortening of telomeres.112 Telomere lengthening 
in kcs1Δ yeast could be reversed by expression of 
active but not inactive Kcs1, indicating that PP-IP 
synthesis by this enzyme is necessary to maintain 
normal telomere length. In another study, it was 
observed that yeast lacking PP-IPs are resistant 
to treatment with wortmannin and caffeine, 
inhibitors of phosphoinositide 3-kinase (PI3K) 
and PI3K-related protein kinases, which are known 
regulators of telomere length.113 Yeast lacking 
Kcs1 showed longer than normal telomeres, but 
interestingly, yeast lacking the IP6 synthesizing 
enzyme Ipk1 showed shortening of telomeres. 
This was attributed to the high levels of inositol 
pyrophosphates PP-IP4 and [PP]2-IP3 synthesized 
from IP5 in these cells, so that the total PP-IP 
component of ipk1Δ yeast is actually higher than 
wild-type yeast. This data showed that any PP-IP 
can act to maintain telomere length, suggesting 
that perhaps protein(s) involved in telomere 
length maintenance are pyrophosphorylation 
targets of PP-IPs.
PP-IPs have been shown to participate in two 
key DNA repair pathways, homologous recom-
bination (HR) mediated repair and nucleotide 
excision repair (NER). The yeast IP6 kinase Kcs1 
(kinase C suppressor-1) was initially identified 
in a genetic screen for second site mutations 
that suppress the hyperrecombination pheno-
type observed in yeast carrying a mutant form 
of protein kinase C (Pkc).114 Subsequently, it was 
shown that the inositol pyrophosphate synthesis 
activity of Kcs1 is essential to support hyperre-
combination in pkc mutant yeast.115 Our data 
revealed that the DNA recombination promoting 
function of PP-IPs is also conserved in mamma-
lian cells.116 When MEFs were allowed to recover 
from DNA damage induced by the replication 
stress-inducer hydroxyurea or the radiomimetic 
antibiotic neocarzinostatin, cells lacking IP6K1 
showed delayed entry into the next phase of the 
cell cycle, and ultimately underwent cell death. 
The DNA repair markers, γ-H2AX, BLM heli-
case, and Rad51 were recruited to the sites of 
DNA damage in Ip6k1−/− MEFs, suggesting that 
HR is initiated in these cells. However, these 
markers persisted for a longer time in Ip6k1−/− 
MEFs, and the DNA breaks were not repaired, 
indicating that repair is incomplete in these 
cells. Expression of active but not inactive IP6K1 
could reverse this phenotype, showing that 5-IP7 
is required to support HR in mammals. It was 
recently reported that IP6K1 also promotes NER 
in an enzyme activity dependent manner.117 
IP6K1 was shown to interact with damage-spe-
cific DNA binding protein 1 (DDB1), which is 
part of the Cullin-RING ubiquitin ligase CRL4 
complex, an E3 ubiquitin ligase that initiates 
NER.118 IP6K1 binding to CRL4 promotes its 
interaction with the COP9 signalosome (CSN) 
to keep the E3 ligase inactive. UV exposure leads 
to dissociation of DDB1 from IP6K1, allowing 
the synthesis of 5-IP7, which acts as a transducer 





3.5.2 Chromatin Remodelling Two independent 
studies highlighted the role of PP-IPs in regulating 
epigenetic modifications in yeast and mammals. 
In budding yeast, PP-IPs were shown to play a 
critical role in regulating the environmental stress 
response. The yeast strain kcs1Δvip1Δ, which is 
incapable of producing any PP-IPs, showed little 
to no transcriptional response to heat, osmotic, or 
oxidative stress.61 These cells displayed a decrease 
in stress dependent histone deacetylation brought 
about by the HDAC complex Rpd3L. A putative 
inositol phosphate binding site was identified on 
the catalytic subunit Rpd3, suggesting that PP-IP 
binding may directly activate Rpd3L to regulate the 
global transcription response to environmental 
stress. Another study identified that mouse IP6K1 
interacts with the histone demethylase JMJD2C 
(Jumonji domain containing 2C).119 Cells lacking 
IP6K1 showed a global reduction in the levels of 
trimethylation on histone H3 lysine 9 (H3K9me3), 
and a concomitant increase in H3K9 acetylation. 
Overexpression of active but not inactive IP6K1 
led to dissociation of JMJD2C from chromatin 
and a consequent increase in H3K9me3 levels. 
It was suggested that IP7 acts on one or more 
chromatin associated proteins to lower JMJD2C 
recruitment to chromatin.
3.5.3 Transcription Regulation Studies in 
budding yeast have shown that PP-IPs control 
transcription to regulate major metabolic pathways. 
The Pho80–Pho85 cyclin-cyclin dependent kinase 
(CDK) complex is responsible for regulating the 
phosphate (Pi) responsive (PHO) pathway by 
phosphorylating the transcription factor Pho4 
to promote its cytoplasmic accumulation. Under 
Pi starvation conditions, the CDK inhibitor 
Pho81 lowers the kinase activity of Pho80–
Pho85, leading to dephosphorylation and nuclear 
translocation of Pho4 to trigger the transcription 
of PHO genes.120, 121 O’Shea and colleagues found 
that PP-IPs produced by Vip1 during phosphate 
starvation lowered Pho4 phosphorylation by the 
Pho80–Pho85–Pho81 complex.57 They further 
determined that 1-IP7 binding to Pho81 triggers 
a structural change that occludes the binding 
of Pho4 to the Pho85 kinase active site, but that 
5-IP7 does not have this effect,
38 highlighting 
how PP-IP binding-mediated regulation of 
protein function is specific to individual PP-IP 
isoforms. Another example of transcription 
regulation by 1-IP7 was seen in the mammalian 
innate immune response.122 1-IP7 but not 5-IP7 
increased phosphorylation and activation of the 
transcription factor IRF3, which is responsible 
for production of the cytokine IFNβ upon viral 
infection. Interestingly, a non-hydrolysable 
analogue of 1-IP7 could not recapitulate this 
effect, suggesting that 1-IP7-mediated specific 
pyrophosphorylation may be involved in this 
pathway. This study provides the only hint that 
PP-IP-mediated protein pyrophosphorylation 
may also be stereo-selective towards a particular 
isoform.
Yeast lacking Kcs1 exhibit inositol auxotro-
phy and decreased intracellular inositol lev-
els.123 This is due to reduced transcription of 
the INO1 gene which encodes myo-inositol-
3-phosphate synthase, the enzyme that converts 
glucose-6-phosphate to inositol-3-phosphate, 
the rate limiting step of de novo inositol syn-
thesis in eukaryotes. Inositol depletion in the 
growth medium led to increased Kcs1 protein 
levels, and PP-IPs synthesized by Kcs1 were 
found to be essential for the upregulation of 
INO1 transcription under these conditions. 
As expression of mouse IP6K1 in kcs1Δ yeast 
rescued their inositol auxotrophy,124 it was 
expected that PP-IP dependent regulation of 
inositol synthesis would be conserved in mam-
mals. However, MEFs lacking IP6K1 exhibited 
an unexpected increase in mammalian Ino1 
transcription, and a corresponding increase 
in inositol levels as compared with wild-type 
MEFs.124 This study further demonstrated that 
IP6K1 is localised to the nucleus by binding to 
the lipid phosphatidic acid, and that PP-IP syn-
thesis by IP6K1 increases methylation of Ino1 
DNA to reduce its transcription. The phenom-
enon of Ino1 transcription regulation by PP-IPs 
is a rare example of evolutionary divergence 
between yeast and mammals with regard to 
the influence of PP-IPs on a specific metabolic 
pathway.
Studies in our laboratory have shown that PP-
IPs regulate rRNA transcription by RNA poly-
merase I in budding yeast.45 kcs1Δ yeast exhibit 
reduced protein synthesis due to a decrease in 
ribosome biogenesis, which in turn is attributed 
to a decrease in rRNA levels. Although there was 
no defect in the recruitment of RNA polymerase 
I on rDNA, the rate of transcription elongation 
was reduced in kcs1Δ as compared with wild-type 
yeast. We identified that 5-IP7 can pyrophospho-
rylate three subunits of the RNA polymerase I 
complex, and suggest that this modification may 
be essential to maintain normal transcription 
elongation by this polymerase. A recent study by 
the Fiedler group has shown that several poten-
tial IP7 pyrophosphorylation targets are nucleo-
lar proteins associated with RNA polymerase I, 
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suggesting that there may be additional proteins 
on which IP7 acts to regulate rRNA synthesis.
125
4  Perspective on the Future
Although PP-IPs were identified more than 
20 years ago, there are still only a handful of 
researchers attempting to uncover the physi-
ological functions of these unique molecules. 
The main reason for the lack of popularity faced 
by these molecules is that their study remains 
technically challenging for most cell biologists. 
There are no commercially available kits for the 
detection and measurement of PP-IPs, no fluo-
rescently tagged or radiolabelled PP-IPs readily 
available for use in protein binding or pyrophos-
phorylation assays, and no easy methods to detect 
pyrophosphorylated proteins. Recent advances 
by the Fiedler, Jessen and Potter laboratories 
are likely to help in surmounting these chal-
lenges.78, 79, 126–129 Highly pure PP-IPs with 
β-phosphate moieties at specific carbon atoms 
have been synthesized by these groups, includ-
ing non-hydrolysable analogues that are stable in 
cells and can bind target proteins but not pyroph-
osphorylate them.47, 78, 130 A system for intracel-
lular delivery and photouncaging of chemically 
synthesized PP-IPs has recently been developed,79 
which promises to open up new methods to study 
the functions of these molecules in different 
subcellular compartments. The use of IP7 as an 
affinity reagent revealed two different classes of 
interacting proteins, depending on the absence or 
presence of the divalent cation Mg2+ during the 
interaction, representing IP7 binding or pyroph-
osphorylation targets respectively.125 These latest 
advances promise a bright future for PP-IPs, with 
the hope that availability of new tools and infor-
mation on novel PP-IP target proteins will draw 
new researchers into examining whether these 
versatile small molecules can regulate the protein 
or pathway of their interest.
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